Image by Sandy Huffaker for The Washington Post via Getty ImagesA new study has found that one of the top names in the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but could actually help prevent the disease.In a new study published in the New England Medical Journal, researchers found that tirzepatide, the active ingredient in Eli Lilly’s Mounjaro diabetes treatment and Zepbound weight loss injectable, cut the risk of developing diabetes by a whopping 94 percent in people who are at high risk of…
